Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
| Review By | Apply | May Apply | Neutral | Avoid | Not Rated |
|---|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 | 0 |
| % | 0 | 0 | 0 | 0 | 0 |
[Dilip Davda] SIPLL is engaged in operating diagnostic testing network primarily in and around Delhi region. It added B2G and B2B model along with B2C to increase its business and earnings. The company posted growth in its top and bottom lines. Boosted bottom lines for FY24 onwards raise eyebrows and concern over its sustainability as it is operating in a highly competitive and fragmented segment. Based on recent financial data, the issue appears fully priced. Only well-informed/cash surplus investors may park moderate funds for medium term, post doing their own due diligence. Read detail review...
Star Imaging IPO Reviews, analysis and views by popular members. Read Star Imaging & Path Lab Ltd. IPO reviews by retail investors to find recommended ipo to buy.
| Review By | Apply | May Apply | Neutral | Avoid |
|---|---|---|---|---|
| Count | 0 | 0 | 0 | 0 |
| % | 0.00 | 0.00 | 0.00 | 0.00 |
| Member | Review |
|---|---|
| No recommendation found. Be the first to post the recommendation. | |
Post Recommendation Manage Recommendations
Note:
RHP